Brokerages Set Roche Holding AG (OTCMKTS:RHHBY) Price Target at $40.00

Shares of Roche Holding AG (OTCMKTS:RHHBY) have received a consensus rating of “Hold” from the six analysts that are covering the company, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and one has assigned a buy rating to the company. The average 12-month target price among analysts that have issued ratings on the stock in the last year is $40.00.

A number of analysts recently weighed in on the stock. Morgan Stanley downgraded shares of Roche from an “equal weight” rating to an “underweight” rating in a research report on Tuesday, January 16th. Argus reiterated a “hold” rating on shares of Roche in a report on Monday, March 4th.

Institutional Trading of Roche

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. First Horizon Advisors Inc. raised its stake in Roche by 19.8% in the fourth quarter. First Horizon Advisors Inc. now owns 2,066 shares of the company’s stock valued at $75,000 after buying an additional 342 shares during the period. Paradigm Asset Management Co. LLC boosted its position in Roche by 18.4% during the third quarter. Paradigm Asset Management Co. LLC now owns 5,151 shares of the company’s stock worth $175,000 after purchasing an additional 800 shares during the period. AlphaMark Advisors LLC acquired a new position in shares of Roche in the first quarter valued at $34,000. Wetzel Investment Advisors Inc. bought a new position in shares of Roche in the fourth quarter valued at about $53,000. Finally, Norman Fields Gottscho Capital Management LLC lifted its stake in shares of Roche by 7.3% during the 1st quarter. Norman Fields Gottscho Capital Management LLC now owns 24,100 shares of the company’s stock worth $769,000 after buying an additional 1,650 shares during the last quarter.

Roche Stock Up 0.8 %

Shares of OTCMKTS RHHBY opened at $30.25 on Thursday. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.04 and a current ratio of 1.35. Roche has a fifty-two week low of $29.80 and a fifty-two week high of $40.48. The company’s 50 day simple moving average is $31.91 and its 200 day simple moving average is $33.61.

Roche Company Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.